sequential revenues were down including FILTER sales, not just grant income
herewith are the exact revenue numbers reported by ctso to the SEC and if you listen to the conference call you will see filter sales absolutely went DOWN from the previous quarter -- but why are we even quibbling over slightly up or down or even, when sales should be doubling or tripling every quarter? and why did the company chose to present results primarily in meaningless year-over-year percentage comparisons instead of explaining why filter sales are not doubling and tripling sequentially? and why does this board's cheerleaders defend the company for their diversion and deception?
folks, there is much to criticize about what is going on including the 70% increase in SGA (even as sales are dropping while the company is not projecting anything but fluctuations) and the extremely flow pace of studies (probably because doctors make the decision on whether to use the filter, not patients). it does not serve our interest well to accept essentially the same happy talk we have been hearing for two years, and it does not help the credibility of this board to forget how long we have been waiting for things to happen (go back and read chan's march 2011 remarks when ce mark was announced) and assuming that it all is magically going to happen next quarter.
I think the SEC should look into the false promotions of some pumpers on this MB regarding company sales numbers that are clearly down quarter to quarter, but "acting like" they are up. Don't these pumpers know there are SEC regulations about "false" statements regarding stocks?
But, on the other hand, if the SEC did look into this they'd likely dismiss the case on those violators here due to being mentally handicapped, and elderly.
From 1st quarter 2013 to 2nd quarter 2012, filter sales dropped. It is a common phenomena to see new products early in their life cycle take a dip after initial stocking orders. CTSO did NOT innvent this.